97 related articles for article (PubMed ID: 22209020)
21. YKL-40 levels and atrial fibrillation in the general population.
Marott SC; Benn M; Johansen JS; Jensen GB; Tybjærg-Hansen A; Nordestgaard BG
Int J Cardiol; 2013 Aug; 167(4):1354-9. PubMed ID: 22525348
[TBL] [Abstract][Full Text] [Related]
22. Plasma homocysteine concentration predicts mortality in non-insulin-dependent diabetic patients with and without albuminuria.
Stehouwer CD; Gall MA; Hougaard P; Jakobs C; Parving HH
Kidney Int; 1999 Jan; 55(1):308-14. PubMed ID: 9893141
[TBL] [Abstract][Full Text] [Related]
23. Elevated circulating levels of the serum acute-phase protein YKL-40 (chitinase 3-like protein 1) are a marker of obesity and insulin resistance in prepubertal children.
Kyrgios I; Galli-Tsinopoulou A; Stylianou C; Papakonstantinou E; Arvanitidou M; Haidich AB
Metabolism; 2012 Apr; 61(4):562-8. PubMed ID: 22036069
[TBL] [Abstract][Full Text] [Related]
24. Serum YKL-40 in risk assessment for colorectal cancer: a prospective study of 4,496 subjects at risk of colorectal cancer.
Johansen JS; Christensen IJ; Jørgensen LN; Olsen J; Rahr HB; Nielsen KT; Laurberg S; Brünner N; Nielsen HJ
Cancer Epidemiol Biomarkers Prev; 2015 Mar; 24(3):621-6. PubMed ID: 25597749
[TBL] [Abstract][Full Text] [Related]
25. Increased levels of YKL-40 and interleukin 6 in patients with chronic pancreatitis and secondary diabetes.
Hansen M; Nielsen AR; Vilsbøll T; Lund A; Krarup T; Knop FK; Vestergaard H
Pancreas; 2012 Nov; 41(8):1316-8. PubMed ID: 22647735
[TBL] [Abstract][Full Text] [Related]
26. YKL-40--an emerging biomarker in cardiovascular disease and diabetes.
Rathcke CN; Vestergaard H
Cardiovasc Diabetol; 2009 Nov; 8():61. PubMed ID: 19930630
[TBL] [Abstract][Full Text] [Related]
27. The interplay of YKL-40 and leptin in type 2 diabetic obese patients.
El-Mesallamy HO; Mostafa AM; Amin AI; El Demerdash E
Diabetes Res Clin Pract; 2011 Sep; 93(3):e113-6. PubMed ID: 21715039
[TBL] [Abstract][Full Text] [Related]
28. Elevated serum YKL-40 level predicts poor prognosis in hepatocellular carcinoma after surgery.
Zhu CB; Chen LL; Tian JJ; Su L; Wang C; Gai ZT; Du WJ; Ma GL
Ann Surg Oncol; 2012 Mar; 19(3):817-25. PubMed ID: 21861215
[TBL] [Abstract][Full Text] [Related]
29. Novel inflammatory marker in dialysis patients: YKL-40.
Okyay GU; Er RE; Tekbudak MY; Paşaoğlu Ö; Inal S; Öneç K; Paşaoğlu H; Altok K; Derici Ü; Erten Y
Ther Apher Dial; 2013 Apr; 17(2):193-201. PubMed ID: 23551676
[TBL] [Abstract][Full Text] [Related]
30. Increased YKL-40 levels in patients with isolated coronary artery ectasia: an observational study.
Erdoğan T; Kocaman SA; Çetin M; Durakoğlugil ME; Kırbaş A; Canga A; Yılmaz A; Doğan S; Çiçek Y
Anadolu Kardiyol Derg; 2013 Aug; 13(5):465-70. PubMed ID: 23728225
[TBL] [Abstract][Full Text] [Related]
31. High serum YKL-40 concentration is associated with cardiovascular and all-cause mortality in patients with stable coronary artery disease.
Kastrup J; Johansen JS; Winkel P; Hansen JF; Hildebrandt P; Jensen GB; Jespersen CM; Kjøller E; Kolmos HJ; Lind I; Nielsen H; Gluud C;
Eur Heart J; 2009 May; 30(9):1066-72. PubMed ID: 19270316
[TBL] [Abstract][Full Text] [Related]
32. High-normal levels of albuminuria predict the development of micro- and macroalbuminuria and increased mortality in Brazilian Type 2 diabetic patients: an 8-year follow-up study.
Murussi M; Campagnolo N; Beck MO; Gross JL; Silveiro SP
Diabet Med; 2007 Oct; 24(10):1136-42. PubMed ID: 17561963
[TBL] [Abstract][Full Text] [Related]
33. Serum YKL-40 predicts adverse clinical outcomes in patients with chronic heart failure.
Bilim O; Takeishi Y; Kitahara T; Ishino M; Sasaki T; Suzuki S; Shishido T; Kubota I
J Card Fail; 2010 Nov; 16(11):873-9. PubMed ID: 21055651
[TBL] [Abstract][Full Text] [Related]
34. Association between serum YKL-40 level and dysglycemia in cystic fibrosis.
Bouvet GF; Maignan M; Arslanian E; Coriati A; Rabasa-Lhoret R; Berthiaume Y
Cytokine; 2015 Feb; 71(2):296-301. PubMed ID: 25497736
[TBL] [Abstract][Full Text] [Related]
35. Usefulness of the triglyceride to high-density lipoprotein cholesterol ratio for predicting mortality risk in type 2 diabetes: role of kidney dysfunction.
Zoppini G; Targher G; Negri C; Stoico V; Gemma ML; Bonora E
Atherosclerosis; 2010 Sep; 212(1):287-91. PubMed ID: 20510417
[TBL] [Abstract][Full Text] [Related]
36. The relationship between serum YKL-40 levels and severity of asthma.
Duru S; Yüce G; Ulasli SS; Erdem M; Kizilgün M; Kara F; Ardıc S
Iran J Allergy Asthma Immunol; 2013 Jul; 12(3):247-53. PubMed ID: 23893808
[TBL] [Abstract][Full Text] [Related]
37. Elevated plasma YKL-40 as a prognostic indicator in patients with idiopathic pulmonary arterial hypertension.
Chen G; Yang T; Gu Q; Ni XH; Zhao ZH; Ye J; Meng XM; Liu ZH; He JG; Xiong CM
Respirology; 2014 May; 19(4):608-15. PubMed ID: 24689969
[TBL] [Abstract][Full Text] [Related]
38. Increased levels of the calcification marker matrix Gla Protein and the inflammatory markers YKL-40 and CRP in patients with type 2 diabetes and ischemic heart disease.
Thomsen SB; Rathcke CN; Zerahn B; Vestergaard H
Cardiovasc Diabetol; 2010 Dec; 9():86. PubMed ID: 21143859
[TBL] [Abstract][Full Text] [Related]
39. Prognostic effect of serum and tissue YKL-40 levels in bladder cancer.
Tschirdewahn S; Reis H; Niedworok C; Nyirady P; Szendröi A; Schmid KW; Shariat SF; Kramer G; vom Dorp F; Rübben H; Szarvas T
Urol Oncol; 2014 Jul; 32(5):663-9. PubMed ID: 24814404
[TBL] [Abstract][Full Text] [Related]
40. Ghrelin-leptin network influences serum chitinase 3-like protein 1 (YKL-40) levels in obese prepubertal children.
Kyrgios I; Galli-Tsinopoulou A; Stylianou C
Regul Pept; 2013 May; 183():69-73. PubMed ID: 23501042
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
